These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9384944)
1. Are attention-deficit hyperactivity disorder and the psychoactive substance use disorders really related? Wilens TE; Spencer TJ; Biederman J Harv Rev Psychiatry; 1995; 3(3):160-2. PubMed ID: 9384944 [No Abstract] [Full Text] [Related]
2. Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders. Wilens TE; Biederman J; Spencer TJ; Frances RJ Hosp Community Psychiatry; 1994 May; 45(5):421-3, 435. PubMed ID: 8045536 [No Abstract] [Full Text] [Related]
3. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. Wilens TE J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375 [TBL] [Abstract][Full Text] [Related]
4. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Biederman J; Wilens T; Mick E; Milberger S; Spencer TJ; Faraone SV Am J Psychiatry; 1995 Nov; 152(11):1652-8. PubMed ID: 7485630 [TBL] [Abstract][Full Text] [Related]
5. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Biederman J; Faraone SV; Keenan K; Benjamin J; Krifcher B; Moore C; Sprich-Buckminster S; Ugaglia K; Jellinek MS; Steingard R Arch Gen Psychiatry; 1992 Sep; 49(9):728-38. PubMed ID: 1514878 [TBL] [Abstract][Full Text] [Related]
12. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders. Milberger S; Faraone SV; Biederman J; Chu MP; Wilens T Arch Pediatr Adolesc Med; 1998 Oct; 152(10):945-51. PubMed ID: 9790603 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. Schubiner H; Tzelepis A; Milberger S; Lockhart N; Kruger M; Kelley BJ; Schoener EP J Clin Psychiatry; 2000 Apr; 61(4):244-51. PubMed ID: 10830144 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. Horner BR; Scheibe KE J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):30-6. PubMed ID: 9000778 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes. Upadhyay N; Chen H; Mgbere O; Bhatara VS; Aparasu RR Subst Use Misuse; 2017 Aug; 52(10):1266-1274. PubMed ID: 28323525 [TBL] [Abstract][Full Text] [Related]
17. Familial transmission of ADHD and psychoactive substance use disorders. Adler LA Am J Psychiatry; 2008 Jan; 165(1):11-2. PubMed ID: 18178750 [No Abstract] [Full Text] [Related]